"Abdominal Aortic Aneurysm Stabilization with mesenchymal stem Cells"

Who can take part

• Subjects with AAA greater than 5 cm in diameter with indication for endovascular treatment, analyzed by aortic AngioCT
• Subjects ≥ 18 years of age at the time of inclusion
• Subjects with a good infrarenal neck for placement of a standard device, neither fenestrated nor branched
• Patients with an estimated life expectancy greater than two years at inclusion
• Women of childbearing potential must have a negative pregnancy test at inclusion and must agree to use highly effective contraceptive methods (diaphragms plus spermicide or male condom plus spermicide, oral contraceptive combined with a second method contraceptive implant, injectable contraceptive, permanent intrauterine device, sexual abstinence or partner with vasectomy) during their participation in the study
• The patient must be able to attend all study visits and abide by all study procedures

Who cannot take part

• Administration of any investigational drug at the time of inclusion or in the three months prior
• Patients with acute myocardial infarction or stroke the previous month
• Patient with major surgery or severe craniocerebral trauma in the 3 months prior to inclusion in the study
• Patients with a history of unresolved neoplasm or hematologic disease
• Patients with uncontrolled arterial hypertension (≥180/110) at inclusion
• Patients with malignant ventricular arrhythmias
• Patients with deep vein thrombosis in the last three months
• Medical or psychiatric illness of any kind that, in the opinion of the investigator, may be a reason for exclusion from the study
• Patients with severe heart failure (New York Heart Association [NYHA] IV) or ejection fraction <20%
• Women who are breastfeeding or pregnant women
• Transplanted patients
• Patient with active septic picture at the time of inclusion